Wednesday, April 15, 2026
The cell therapy sector remains constrained by particulate guidance based on traditional parenteral products, says a BioPhorum publication.
In theory, in vivo makes other cell therapies obsolete, but a panel at BPI Europe in Vienna last month painted a more measured picture.
Thursday, October 01, 2026
Esmond Lee, senior scientist at the Singapore-based research institute, set out the work in an interview at Sartorius's Process Intensification Forum in Hyderabad, India.